Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for black patients with heart failure

被引:0
|
作者
Tam, SW
Linde-Zwirble, WT
Worcel, M
Sabolinski, ML
Ghali, JK
Villagra, VG
Winkelmayer, WC
Angus, DC
机构
[1] ZD Associates, Perkasie, PA USA
[2] NitroMed Inc, Lexington, MA USA
[3] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA USA
[4] Hlth & Technol Vector Inc, Farmington, CT USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3031
引用
收藏
页码:U705 / U705
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure
    Angus, DC
    Linde-Zwirble, WT
    Tam, SW
    Ghali, JK
    Sabolinski, ML
    Villagra, VG
    Winkelmayer, WC
    Worcel, M
    CIRCULATION, 2005, 112 (24) : 3745 - 3753
  • [2] A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination
    Cheng, Judy W. M.
    CLINICAL THERAPEUTICS, 2006, 28 (05) : 666 - 678
  • [3] Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial
    Anand, Inder S.
    Tam, S. William
    Rector, Thomas S.
    Taylor, Anne L.
    Sabolinski, Michael L.
    Archambault, W. Tad
    Adams, Kirkwood F.
    Olukotun, Adeoye Y.
    Worcel, Manuel
    Cohn, Jay N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (01) : 32 - 39
  • [4] Fixed-dose combination of isosorbide dinitrate/hydralazine improves outcomes in elderly heart failure patients in the African-American Heart Failure Trial
    Taylor, A.
    Sabolinski, M.
    Tam, S. W.
    Worcel, M.
    Cohn, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 49 - 49
  • [5] African American Heart Failure trial: Efficacy of a fixed dose combination of isosorbide dinitrate and hydralazine in heart failure
    Taylor, AL
    Ziesche, S
    Yancy, C
    Carson, P
    D'Agostino, R
    Ferdinand, K
    Taylor, M
    Adams, K
    Sabolinski, M
    Worcel, M
    Cohn, J
    CIRCULATION, 2005, 111 (13) : 1726 - 1726
  • [6] Fixed-dose combination of isosorbide dinitrate and hydralazine reduces heart failure hospitalizations, length of stay, and cost in African-American Heart Failure Trial (A-HeFT)
    Linde-Zwirble, WT
    Tam, SW
    Sabolinski, M
    Ghali, J
    Villagra, VG
    Winkelmayer, WC
    Angus, DC
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S149 - S149
  • [7] Effect of spironolactone use on the benefit of fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American heart failure trial
    Ghali, Jalal K.
    Tam, S. William
    Taylor, Anne L.
    Cohn, Jay N.
    Worcel, Manuel
    Sabolinski, Michael L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 63A - 63A
  • [8] Effect of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in Elderly Patients in the African-American Heart Failure Trial
    Taylor, Anne L.
    Sabolinski, Michael L.
    Tam, S. William
    Ziesche, Susan
    Ghali, Jalal K.
    Archambault, W. Tad
    Worcel, Manuel
    Cohn, Jay N.
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (08) : 600 - 606
  • [9] Effects of ACE Inhibitors or ↓-Blockers in Patients Treated with the Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine in the African-American Heart Failure Trial
    Jalal K. Ghali
    S. William Tam
    Keith C. Ferdinand
    JoAnn Lindenfeld
    Michael L. Sabolinski
    Anne L. Taylor
    Manuel Worcel
    Charles L. Curry
    Jay N. Cohn
    American Journal of Cardiovascular Drugs, 2007, 7 : 373 - 380
  • [10] Effects of ACE inhibitors or β-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial
    Ghali, Jalal K.
    Tam, S. William
    Ferdinand, Keith C.
    Lindenfeld, JoAnn
    Sabolinski, Michael L.
    Taylor, Anne L.
    Worcel, Manuel
    Curry, Charles L.
    Cohn, Jay N.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2007, 7 (05) : 373 - 380